Smoking cessation is associated with regression of electrocardiographic left ventricular hypertrophy, independent of weight gain or increases in blood pressure.
Key Findings
Results
Average left ventricular voltage decreased significantly over 6 years following smoking cessation.
Mean LV voltage decreased from 2.47 mV at baseline to 2.41 mV at 6-year follow-up (p < 0.0001)
Study analyzed 752 non-hypertensive participants (695 males; mean age 47.8 ± 9.2 years)
Left ventricular hypertrophy was defined using the Sokolow-Lyon criteria (SV1 + RV5 > 3.5 mV)
This was a retrospective observational study using data from annual health checkups
Results
The prevalence of electrocardiographic left ventricular hypertrophy declined from 8.4% to 6.5% over 6 years after smoking cessation.
Baseline LVH prevalence was 8.4% using the Sokolow-Lyon criteria
At 6-year follow-up, LVH prevalence had fallen to 6.5%
LVH regression occurred in both participants who received antihypertensive medication and in those who did not
Results
LVH regression following smoking cessation occurred despite significant increases in body weight and systolic blood pressure.
Body weight increased significantly from 65.7 kg to 68.1 kg (p < 0.0001)
Systolic blood pressure increased significantly from 112.8 mmHg to 122.0 mmHg (p < 0.0001)
The regression of LVH was described as independent of weight gain or increases in blood pressure
Participants were non-hypertensive at baseline
Results
Antihypertensive medication was identified as an independent predictor of electrocardiographic LVH regression in multivariable analysis.
Multivariable logistic regression analysis was used to identify predictors of LVH progression
Antihypertensive medication use was the only independent predictor of LVH regression identified
LVH regression was observed in participants both with and without antihypertensive medication
Methods
The study population was predominantly male and middle-aged, drawn from participants undergoing annual health checkups.
752 total participants; 695 were male
Mean age was 47.8 ± 9.2 years
Participants were non-hypertensive at enrollment
6-year retrospective observational design using health checkup data
What This Means
This research suggests that quitting smoking is linked to a reduction in an abnormality called left ventricular hypertrophy (LVH), which is a thickening or enlargement of the heart's main pumping chamber detectable on an electrocardiogram (ECG). LVH is a known risk factor for serious heart problems. The study followed 752 mostly male, non-hypertensive participants for 6 years after they stopped smoking and found that average heart voltage readings decreased and the proportion of participants with LVH dropped from about 8.4% to 6.5%.
A notable finding was that this improvement in heart measures happened even though the participants gained weight and had increases in blood pressure after quitting smoking — two changes that would typically be expected to worsen LVH. The benefit of smoking cessation on LVH appeared to work through a separate mechanism from these other factors. People who were also taking blood pressure medications were especially likely to show LVH regression, but improvement was seen even in those not on such medications.
This research suggests that the cardiovascular benefits of quitting smoking may extend beyond just reducing blood pressure or preventing weight gain, and may directly help reverse certain structural heart changes. The findings add to the understanding of why smoking cessation is recommended as a key step in protecting heart health, and highlight that even people who gain weight after quitting may still experience meaningful cardiac benefits.
Ninomiya Y, Kawasoe S, Kubozono T, Sai E, Nuruki N, Kamada H, et al.. (2026). Smoking cessation is associated with regression of electrocardiographic left ventricular hypertrophy: A 6-year retrospective observational study.. PloS one. https://doi.org/10.1371/journal.pone.0357409